3 bouknight - uab · 2/23/2015 1 update from the ivf lab: preimplantationgenetic testing janet...
TRANSCRIPT
2/23/2015
1
Update from the IVF Lab:Preimplantation Genetic Testing
Janet McLaren Bouknight, MDReproductive Endocrinology and InfertilityDepartment of Obstetrics & Gynecology
Educational Objectives
• Gain familiarity with the procedures and pregnancy outcomes of current in vitro fertilization practices.
• Understand the application of Preimplantation Genetic Diagnosis (PGD) for single‐gene disorders.
• Appreciate the role of Preimplantation Genetic Screening (PGS) in maximizing IVF cycle efficiency and encouraging elective single embryo transfer.
Current IVF Practice
2/23/2015
2
Current IVF Practice
150,000 cycles
65,000 livebirths
Current IVF Practice
All SART Clinics 2012 <35 35‐37 38‐40 41‐42 >42
Pregnancy Rate 47% 38% 30% 20% 9%
Live Birth Rate 41% 31% 22% 12% 4%
# embryos transfer 1.9 2.0 2.4 2.9 2.9
Current IVF Practice
% Twins 30% 25% 20% 13% 9%
• What are the advanced that have contributed to an increase in success in the IVF Lab?
• Improved lab conditions
• Extended embryo culture
• Improvements in embryo cryopreservation
2/23/2015
3
Current IVF Practice:Improved Lab Conditions
Current IVF Practice:Improved Lab Conditions
Current IVF Practice:Improved Lab Conditions
2/23/2015
4
Current IVF Practice:Extended Embryo Culture
Day 5: Blastocyst StageDay 3: Cleavage Stage
• 8‐cells• 30% implantation rate
• 200‐300 cells• 50% implantation rate
Increased live birth rates seen in “good prognosis” patients who undergo a Day 5 transfer
Current IVF Practice:Extended Embryo Culture
Current IVF Practice:Extended Embryo Culture
• Supports blastocyst transfer for “good prognosis” patients
• Opportunity to consider single embryo transfer
• May be associated with a small increased risk of monozygotic twinning
2/23/2015
5
Current IVF Practice:Embryo Cryopreservation Cycles
• Improvements in freezing techniques (vitrification) have increased success of cryopreserved embryos.
I i i ti th t• Increasing appreciation that the endometrial environment created by ovarian hyperstimulationmay not be the most favorable for implantation
Kalra Obstet Gynecol 2011; 118(4): 863Wu JARG 2014; 31(3):275Maheshwari Fertil Steril 2012; 98(2): 368
Current IVF Practice:Embryo Cryopreservation Cycles
Current IVF Practice:Embryo Cryopreservation Cycles
Maheshwari Fertil Steril 2012; 98(2): 368
Cryo transfers may provide better obstetrical and perinatal outcomes than fresh transfers.
2/23/2015
6
Preimplantation Genetic DiagnosisPGD
PreimplantationGenetic Diagnosis (PGD)• Allows patients who are carriers of or affected by genetic conditions select unaffected embryos for transfer prior to becoming pregnant
• Decreases chance of sick child/neonatal loss
• Avoids difficult decision to terminate pregnancy
• Single‐gene disorders
Cystic FibrosisSickle Cell AnemiaSpinal Muscular AtrophyOcular Albinism
HuntingtonsMyotonic dystrophyTuberous sclerosus
HemophiliaΒ‐ThalassemiaNF1FAP
PreimplantationGenetic Diagnosis (PGD)• First pregnancies from PGD reported in 1990
• 2 cases, both X‐linked: adrenoleukodystrophy and x‐linked mental retardation.
• Y chromosome‐specific sequence amplified from embryo biopsy and only female embryos transferred
• As of 2008 66% of IVF centers offer preimplantationgenetic testing (PGT)
• PGT was used in 4% of all non‐donor IVF cycles
• Majority of genetic testing is sent out, not done in house
• Natera, Reprogenetics, LabCorp, Genesis
2/23/2015
7
PGD: Current practice
• Biopsy is typically done on blastocyst (day 5)
Trophectoderm(placental)
• Sample of cells are taken from the trophectoderm
• Embryo is frozen
• After results, embryo is selected for frozen transfer
Inner cell mass (fetal)
Zona pellucida
Biopsy
PGD: Additional Concerns
• Aneuploidy screening is commonly performed in conjunction with PGD testing.
• Cost: $5000 for lab to test biopsies, + IVF charges ($12 000 $15 000)($12,000‐$15,000).
• Gray areas:• Adult‐onset disease
• Cancer‐causing genes
• HLA‐matching for sibling
Preimplantation Genetic ScreeningPGS
2/23/2015
8
PreimplantationGenetic Screening (PGS)
• Goal = to identify the embryo(s) that will lead to a live birth:
• Morphology
• Metabolomics/secretome
• Cytokinetics/time‐lapse imaging
• Genetic Screening
• Significant percentage of human embryos are aneuploid
• PGS identifies euploid embryos for transfer
Embryo Aneuploidy and Age
2701 patients / 3,392 cycles 15,169 embryo biopsy results
20‐80% based on age
Franasiak Fertil Steril 2014; 101:656
PGS: Target population
• Initially targeted toward populations at higher risk for aneuploid embryos:
• Advanced Reproductive Age
• Recurrent Pregnancy LossRecurrent Pregnancy Loss
• Multiple failed IVF cycles
• Increasing appreciation of technique for “good prognosis” patients to increase the efficiency of IVF.
• Increases patient and provide willingness to consider an elective single embryo transfer (eSET).
2/23/2015
9
PGS: Technique
• Initial aneuploidy screening
was done with FISH
• Fluorochrome‐tagged DNA
probe binds to DNA targetprobe binds to DNA target
• 5‐8 probes can be used (13, 18, 21, X, Y)
• Detects chromosome number and large deletions
• Multiple clinical trials did not show a benefit of FISH‐based PGS; actually decreased live birth rates
• Incomplete detection, mosaicism at cleavage‐stage
PGS: New Techniques
• Newer platforms allow for Comprehensive Chromosomal Screening (CCS)
• All 24 chromosomes
• Finer resolution
• Current methods:
• Single nucleotide polymorphisms (SNP) microarrays
• Array comparative genomic hybridization (aCGH)
• Quantitative real‐time PCR (qPCR)
• aCGH and qPCR will not detect balanced rearrangements and polyploidy
PGS: CCS Outcomes
• BEST Trial (2013)• RCT of N = 205 couples with female partner ≤42yo
• Normal ovarian reserve testing
• Randomized if ≥ 2 blasts on day 5
1) PGS CCS with transfer of single euploid blast
OR
2) No screening and transfer of two untested blasts
Forman Fertil Steril 2013; 100(1):100
2/23/2015
10
CCS Outcomes
Euploid eSET• 61% preg rate• No twins
*
Forman Fertil Steril2013; 100(1):100
2 blast transfer• 65% preg rate• 46% twins• 2% triplets
CCS OutcomesAll single embryo transfer: PGS/CCS vs Untested, by age
Forman Fertil Steril 2013; 100(1):100
* *
eSET Nationwide
15% of cycles in < 35 years
2/23/2015
11
Outcome in <35yo eligible for eSET
Conclusions
• Continued advances in laboratory and clinical practices that improve the IVF outcomes of our patients.
• PGD is a treatment available to those with genetic disease that is only increasing in accuracy and efficiency.
• PGS = Game Changer
• Screening with CCS appears to increase live birth rates and reduce multiples
• Route to eSET
UAB IVF Team
2/23/2015
12
SART IVF Predictor: 25yo with PCOS
2 months laterFrozen Embryo Transfer: $2500
SART IVF Predictor: 38yo unexplained
2 months laterFrozen Embryo Transfer: $2500